Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 871648, 12 pages
http://dx.doi.org/10.1155/2013/871648
Research Article

Effects of Korean Red Ginseng and HAART on vif Gene in 10 Long-Term Slow Progressors over 20 Years: High Frequency of Deletions and G-to-A Hypermutation

1Department of Microbiology, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Republic of Korea
2Department of Pathology, Seoul National University Boramae Hospital, Seoul 156-707, Republic of Korea

Received 12 June 2013; Accepted 3 September 2013

Academic Editor: K. B. Harikumar

Copyright © 2013 Young Keol Cho et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Ernst, “Panax ginseng: an overview of the clinical evidence,” Journal of Ginseng Research, vol. 34, no. 4, pp. 259–263, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. K. T. Choi, “Botanical characteristics, pharmacological effects and medicinal components of Korean Panax ginseng C A Meyer,” Acta Pharmacologica Sinica, vol. 29, no. 9, pp. 1109–1118, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. S. J. Fulder, “Ginseng and the hypothalamic-pituitary control of stress,” The American Journal of Chinese Medicine, vol. 9, no. 2, pp. 112–118, 1981. View at Google Scholar · View at Scopus
  4. V. K. Singh, S. S. Agarwal, and B. M. Gupta, “Immunomodulatory activity of Panax ginseng extract,” Planta Medica, vol. 50, no. 6, pp. 462–465, 1984. View at Google Scholar · View at Scopus
  5. X. Song and S. Hu, “Adjuvant activities of saponins from traditional Chinese medicinal herbs,” Vaccine, vol. 27, no. 36, pp. 4883–4890, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. D. G. Yoo, M. C. Kim, M. K. Park et al., “Protective effect of ginseng polysaccharides on influenza viral infection,” PLoS ONE, vol. 7, no. 3, Article ID e33678, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. H. X. Sun, Y. P. Ye, H. J. Pan, and Y. J. Pan, “Adjuvant effect of Panax notoginseng saponins on the immune responses to ovalbumin in mice,” Vaccine, vol. 22, no. 29-30, pp. 3882–3889, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Sun, S. Hu, and X. Song, “Adjuvant effects of protopanaxadiol and protopanaxatriol saponins from ginseng roots on the immune responses to ovalbumin in mice,” Vaccine, vol. 25, no. 6, pp. 1114–1120, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. P. W. Hunt, “HIV and inflammation: mechanisms and consequences,” Current HIV/AIDS Reports, vol. 9, no. 2, pp. 139–147, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Yayeh, K. H. Jung, H. Y. Jeong et al., “Korean red ginseng saponin fraction downregulates proinflammatory mediators in LPS stimulated RAW264. 7 cells and protects mice against endotoxic shock,” Journal of Ginseng Research, vol. 36, no. 3, pp. 263–269, 2012. View at Publisher · View at Google Scholar
  11. A. T. Smolinski and J. J. Pestka, “Modulation of lipopolysaccharide-induced proinflammatory cytokine production in vitro and in vivo by the herbal constituents apigenin (chamomile), ginsenoside Rb1 (ginseng) and parthenolide (feverfew),” Food and Chemical Toxicology, vol. 41, no. 10, pp. 1381–1390, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Rhule, S. Navarro, J. R. Smith, and D. M. Shepherd, “Panax notoginseng attenuates LPS-induced pro-inflammatory mediators in RAW264.7 cells,” Journal of Ethnopharmacology, vol. 106, no. 1, pp. 121–128, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. J. M. Brenchley, D. A. Price, T. W. Schacker et al., “Microbial translocation is a cause of systemic immune activation in chronic HIV infection,” Nature Medicine, vol. 12, no. 12, pp. 1365–1371, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. K. Cho, J. Y. Lim, Y. S. Jung, S. K. Oh, H. J. Lee, and H. Sung, “High frequency of grossly deleted nef genes in HIV-1 infected long-term slow progressors treated with Korean red ginseng,” Current HIV Research, vol. 4, no. 4, pp. 447–457, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. K. Cho and Y. S. Jung, “High frequency of gross deletions in the 5′ LTR and gag regions in HIV type 1-infected long-term survivors treated with Korean red ginseng,” AIDS Research and Human Retroviruses, vol. 24, no. 2, pp. 181–193, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. K. Cho, Y. S. Jung, and H. S. Sung, “Frequent gross deletion in the HIV type 1 nef gene in hemophiliacs treated with korean red ginseng: inhibition of detection by highly active antiretroviral therapy,” AIDS Research and Human Retroviruses, vol. 25, no. 4, pp. 419–424, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. V. Sandonís, C. Casado, T. Alvaro et al., “A combination of defective DNA and protective host factors are found in a set of HIV-1 ancestral LTNPs,” Virology, vol. 391, no. 1, pp. 73–82, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. H. R. Rangel, D. Garzaro, A. K. Rodríguez et al., “Deletion, insertion and stop codon mutations in vif genes of HIV-1 infecting slow progressor patients,” Journal of Infection in Developing Countries, vol. 3, no. 7, pp. 531–538, 2009. View at Google Scholar · View at Scopus
  19. Y. K. Cho, J. E. Kim, and B. T. Foley, “Phylogenetic analysis of near full-length HIV-1 genomic sequences in 21 Korean individuals,” AIDS Research and Human Retroviruses, vol. 29, no. 4, pp. 738–743, 2013. View at Publisher · View at Google Scholar
  20. Y. K. Cho, Y. S. Jung, J. S. Lee, and B. T. Foley, “Molecular evidence of HIV-1 transmission in 20 Korean individuals with haemophilia: phylogenetic analysis of the vif gene,” Haemophilia, vol. 18, no. 2, pp. 291–299, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. P. P. Rose and B. T. Korber, “Detecting hypermutations in viral sequences with an emphasis on G→A hypermutation,” Bioinformatics, vol. 16, no. 4, pp. 400–401, 2000. View at Google Scholar · View at Scopus
  22. S. Fourati, S. Lambert-Niclot, C. Soulie et al., “HIV-1 genome is often defective in PBMCs and rectal tissues after long-term HAART as a result of APOBEC3 editing and correlates with the size of reservoirs,” Journal of Antimicrobial Chemotherapy, vol. 67, no. 10, pp. 2323–2326, 2012. View at Publisher · View at Google Scholar
  23. U. Wieland, A. Seelhoff, A. Hofmann et al., “Diversity of the vif gene of human immunodeficiency virus type 1 in Uganda,” Journal of General Virology, vol. 78, no. 2, pp. 393–400, 1997. View at Google Scholar · View at Scopus
  24. P. Sova, M. van Ranst, P. Gupta et al., “Conservation of an intact human immunodeficiency virus type 1 vif gene in vitro and in vivo,” Journal of Virology, vol. 69, no. 4, pp. 2557–2564, 1995. View at Google Scholar · View at Scopus
  25. T. Yamada and A. Iwamoto, “Comparison of proviral accessory genes between long-term nonprogressors and progressors of human immunodeficiency virus type 1 infection,” Archives of Virology, vol. 145, no. 5, pp. 1021–1027, 2000. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Tominaga, S. Kato, M. Negishi, and T. Takano, “A high frequency of defective vif genes in peripheral blood mononuclear cells from HIV type 1-infected individuals,” AIDS Research and Human Retroviruses, vol. 12, no. 16, pp. 1543–1549, 1996. View at Google Scholar · View at Scopus
  27. Y. K. Cho, H. Sung, I. G. Bae et al., “Full sequence of HIV type 1 Korean subtype B in an AIDS case with atypical seroconversion: TAAAA at TATA box,” AIDS Research and Human Retroviruses, vol. 21, no. 11, pp. 961–964, 2005. View at Google Scholar
  28. L. Alexander, M. J. Aquino-DeJesus, M. Chan, and W. A. Andiman, “Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by a two-amino-acid insertion in HIV-1 Vif from a nonprogressing mother and child,” Journal of Virology, vol. 76, no. 20, pp. 10533–10539, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. K. Cho, Y. S. Jung, H. S. Sung, and C. H. Joo, “Frequent genetic defects in the HIV-1 5′LTR/gag gene in hemophiliacs treated with Korean red ginseng: decreased detection of genetic defects by highly active antiretroviral therapy,” Journal of Ginseng Research, vol. 35, no. 4, pp. 413–420, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Nascimbeni, M. Bouyac, F. Rey, B. Spire, and F. Clavel, “The replicative impairment of Vif-mutants of human immunodeficiency virus type 1 correlates with an overall defect in viral DNA synthesis,” Journal of General Virology, vol. 79, no. 8, pp. 1945–1950, 1998. View at Google Scholar · View at Scopus
  31. J. P. Vartanian, M. Henry, and S. Wain-Hobson, “Sustained G→A hypermutation during reverse transcription of an entire human immunodeficiency virus type 1 strain Vau group O genome,” Journal of General Virology, vol. 83, no. 4, pp. 801–805, 2002. View at Google Scholar · View at Scopus
  32. T. L. Kieffer, P. Kwon, R. E. Nettles, Y. Han, S. C. Ray, and R. F. Siliciano, “G→A hypermutation in protease and reverse transcriptase regions of human immunodeficiency virus type 1 residing in resting CD4+ T cells in vivo,” Journal of Virology, vol. 79, no. 3, pp. 1975–1980, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. B. Wang, M. Mikhail, W. B. Dyer, J. J. Zaunders, A. D. Kelleher, and N. K. Saksena, “First demonstration of a lack of viral sequence evolution in a nonprogressor, defining replication-incompetent HIV-1 infection,” Virology, vol. 312, no. 1, pp. 135–150, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. G. Hassaine, I. Agostini, D. Candotti et al., “Characterization of human immunodeficiency virus type 1 vif gene in long-term asymptomatic individuals,” Virology, vol. 276, no. 1, pp. 169–180, 2000. View at Publisher · View at Google Scholar · View at Scopus
  35. F. A. de Maio, C. A. Rocco, P. C. Aulicino, R. Bologna, A. Mangano, and L. Sen, “Unusual substitutions in HIV-1 Vif from children infected perinatally without progression to AIDS for more than 8 years without therapy,” Journal of Medical Virology, vol. 84, no. 12, pp. 1844–1852, 2012. View at Publisher · View at Google Scholar
  36. M. Janini, M. Rogers, D. R. Birx, and F. E. McCutchan, “Human immunodeficiency virus type 1 DNA sequences genetically damaged by hypermutation are often abundant in patient peripheral blood mononuclear cells and may be generated during near-simultaneous infection and activation of CD4+ T cells,” Journal of Virology, vol. 75, no. 17, pp. 7973–7986, 2001. View at Publisher · View at Google Scholar · View at Scopus
  37. G. H. Kijak, L. M. Janini, S. Tovanabutra et al., “Variable contexts and levels of hypermutation in HIV-1 proviral genomes recovered from primary peripheral blood mononuclear cells,” Virology, vol. 376, no. 1, pp. 101–111, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. E. W. Refsland, J. F. Hultquist, and R. S. Harris, “Endogenous origins of HIV-1 G-to-A hypermutation and restriction in the nonpermissive T cell line CEM2n,” PLoS Pathogens, vol. 8, no. 7, Article ID e1002800, 2012. View at Publisher · View at Google Scholar